We are live on ! Find out more
SF

Scott Ferguson Sachem Head Capital Management

AUM $4.82B
1-Year Est. Return 73.38%
 

Scott Ferguson is the founder of Sachem Head Capital Management, an activist and fundamental equity firm. He previously worked at firms including Corvex and built a reputation for research-driven campaigns at public companies. Ferguson’s filings and activist situations are followed closely in event-driven and engagement-oriented investing circles.

This Fund
S&P 500
This Quarter Est. Return
+14.04%
1 Year Est. Return
+73.38%
3 Year Est. Return
+171.97%
5 Year Est. Return
+150.29%
10 Year Est. Return
+1,107.59%
AUM
$1.51B
AUM Growth
+$166M
Cap. Flow
+$17.8M
Cap. Flow %
1.18%
Top 10 Hldgs %
100%
Holding
9
New
2
Increased
–
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$106M
2
BIO icon
Bio-Rad Laboratories Class A
BIO
+$34.7M

Top Sells

Rank Stock Value
1
DG icon
Dollar General
DG
+$93.7M
2
VTRS icon
Viatris
VTRS
+$29.6M

Sector Composition

Rank Sector Weight
1 Healthcare 39.39%
2 Industrials 39.17%
3 Materials 8.72%
4 Communication Services 4.42%
5 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDK
1
DELISTED
CDK Global, Inc.
CDK
$591M 39.17%
12,647,333
– –
AGN
2
DELISTED
Allergan plc
AGN
$238M 15.77%
800,000
– –
ZTS icon
3
Zoetis
ZTS
$32.1B
$203M 13.47%
4,395,000
– –
APD icon
4
Air Products & Chemicals
APD
$67.9B
$132M 8.72%
940,470
– –
SLXP
5
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$125M 8.31%
+725,000
New +$106M
VTRS icon
6
Viatris
VTRS
$18.7B
$115M 7.64%
1,945,000
-520,000
-21% -$29.6M
TFCFA
7
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$66.7M 4.42%
1,971,762
– –
BIO icon
8
Bio-Rad Laboratories Class A
BIO
$10.2B
$37.9M 2.51%
+280,000
New +$34.7M
DG icon
9
Dollar General
DG
$27.2B
– –
-1,325,000
Closed -$93.7M

Similar funds

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
FAM
Fenimore Asset Management Cobleskill, New York $4.83B AUM 9.09% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
AG
AlTi Global New York $4.84B AUM 25.68% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return
TI
Truepoint Inc Cincinnati, Ohio $4.79B AUM 16.42% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return

Scott Ferguson's Q1 2015 Portfolio in Review

As of Q1 2015, Scott Ferguson held 9 positions worth $1.51B, up 12% from $1.34B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Scott Ferguson's Q1 2015 filing shows 2 new, 1 reduced and 1 closed positions. Its largest new stake was SALIX PHARMACEUTICALS LTD DEL: 725,000 shares worth $125M. The largest sale was Dollar General, an estimated $93.7M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 40% a quarter earlier, followed by Industrials and Materials.

  • Scott Ferguson's largest Q1 2015 buy was SALIX PHARMACEUTICALS LTD DEL: 725,000 shares worth $125M.
  • Scott Ferguson's biggest Q1 2015 reduction was Viatris, cutting an estimated $29.6M.
  • Scott Ferguson fully exited Dollar General in Q1 2015, selling an estimated $93.7M.
  • Scott Ferguson's ten largest holdings make up 100% of its $1.51B portfolio in Q1 2015.
  • Scott Ferguson opened 2 new positions and closed 1 in Q1 2015.
  • Scott Ferguson's portfolio value rose 12% quarter-over-quarter to $1.51B.

Based on Sachem Head Capital Management's 13F filing for Q1 2015, filed 15 May 2015.